Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2012Angewandte Chemie International Edition

Inhibitors for the Immuno‐ and Constitutive Proteasome: Current and Future Trends in Drug Development

View Full Paper
Ask AI
Bookmark
Share

Authors

EHE.M. HuberUniversität InnsbruckMGM. GrollBioscience Research

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Huber et al. (2012) studied this question.

synapsesocial.com/papers/6a910f3f17bbbfe73e7457a2https://doi.org/10.1002/anie.201201616
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Peptide transport by the multidrug resistance pump.1992 · 149 citations
  2. 2Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency1999 · 117 citations
  3. 3Crystal Structure of the 20 <i>S</i> Proteasome from the Archaeon <i>T. acidophilum</i> at 3.4 Å Resolution1995 · 1,532 citations
  4. 4Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma2004 · 341 citations
  5. 5Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome2009 · 1,812 citations